UK not buying AstraZeneca’s COVID-19 antibody drug over lack of data
The U.K. has no plans to buy doses of AstraZeneca’s COVID-19 antibody therapy Evusheld that is designed to protect vulnerable people, arguing that the data for the drug is insufficient. Read More